VIXTIMOTAMAB

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 03:38:02 GMT 2025` Edited by `admin` on `Wed Apr 02 03:38:02 GMT 2025`
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type	FAB
Sequence Type	COMPLETE
Record UNII	56FUB33G5M
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

AMV-564

Preferred Name

English

VIXTIMOTAMAB

Official Name

English

CNTO 3953 TANDAB

Code

English

T652

Code

English

T-652

Code

English

MMUNOGLOBULIN, BISPECIFIC TETRAVALENT, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL AMV564 .KAPPA.-CHAIN VL1) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER1) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD33 ANTIGEN) (HUMAN MONOCLONAL AMV564 SINGLE-CHAIN

Common Name

English

vixtimotamab [INN]

Common Name

English

AMV564

Code

English

MABFRAG HUMAN (FAB) ANTI P20138 (CD33_HUMAN)MABFRAG HUMAN (FAB) ANTI P07766 (CD3_HUMAN) (AMV564)

Common Name

English

IMMUNOGLOBULIN, BISPECIFIC TETRAVALENT, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL AMV564 .KAPPA.-CHAIN VL1) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER1) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD33 ANTIGEN) (HUMAN MONOCLONAL AMV564 SINGLE-CHAI

Systematic Name

English

CNTO-3953

Code

English

AMV 564 [WHO-DD]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

593317